Financial PerformanceGrowth is improving, margins are expanding, there is capital to deploy, estimates are now poised to move up, and shares currently trade at FCF parity.
Market PositionDHR is viewed as a leader in the attractive market of bioprocess tools, maintaining its position as a diversified consolidator in life science tools and diagnostics.
Product InnovationThe launch of the new on-sequencer protocol for the Element AVITI system will reduce process steps, hands-on-time, and potential errors, improving overall efficiency.